CRD.A enters its May 4 earnings call with short sellers at their most aggressive in over six weeks — and a new CEO in the chair for the first time.
Short interest has surged over the past month. The SI % FF climbed from roughly 1.9% in mid-March to 3.3% now — a near-doubling over six weeks. The sharpest move came this week: shorts jumped by about 15% week-on-week between April 23 and April 28, adding roughly 70,000 shares in a single session. The official FINRA fortnightly figure, settled April 15, came in at 524,000 shares — closely matching the daily estimate, which gives confidence in the direction of travel. Days to cover, at 11.5, reflect the stock's thin liquidity and make any abrupt short squeeze mathematically challenging to execute. Still, at 3.3% of the free float, this is a modest absolute short position, not an extreme one.
The borrow market paints a relaxed picture. Cost to borrow is running at just 0.71% annualised — barely above the risk-free rate and largely unchanged over the week, up less than 1%. Availability has not meaningfully tightened; the ORTEX short score of 45.6 has crept higher through the month, rising from the low 40s in mid-April, but remains well short of the elevated readings that typically precede squeeze dynamics. The utilization rate of 2.9% is far below the 52-week peak of 6.7%, confirming that the lending pool has plenty of room. Options positioning adds a contrarian wrinkle: the put/call ratio has dropped to 0.33, well below its 20-day average of 0.47, suggesting that options participants are not particularly worried — or are simply betting on a recovery after the stock's strong April.
The stock itself has had a good month despite the short rebuild. CRD.A is up 13% over the past 30 days to $10.83, clawing back losses from earlier in the year. The week was almost flat, up 0.4%, with a small 1.4% pullback on Wednesday. The biggest backdrop story is the leadership change: W. Bruce Swain Jr. was named President and CEO on March 31, with former CEO Rohit Verma departing. Swain was already the CFO, so the transition is internal — but it means the May 4 call will be the first under new leadership, and the first with a newly realigned segment structure that took effect January 1. Both factors typically attract more scrutiny from analysts and investors.
Insider activity in March was mostly equity-award related and low in significance. The former CEO Verma sold 27,587 shares at $10.76 for roughly $297,000. The outgoing CFO Swain — now the CEO — sold 14,364 shares at the same price for around $155,000. A divisional CEO also sold 11,213 shares. These sales coincided with stock award grants, the standard pattern for executives exercising and selling a portion of freshly vested shares. Net across 90 days, insiders are still modestly positive at roughly $1.7m in net value bought — though the bulk of that is likely wash from award-offset sales. No open-market buying of note has been filed. On the ownership side, Jesse Crawford, the founding family's controlling interest, holds nearly 48% of shares — concentration that limits float and therefore exaggerates any positioning-based metrics.
The recent earnings track record warrants attention. The last reported quarter (March 3) produced a 1-day decline of 1.3% and a 5-day decline of 10.4%. The preceding print was worse: down 3.2% on day one and 6.6% by day five. Two consecutive earnings events that both ended lower on a five-day horizon is a meaningful pattern for a stock with this kind of float constraint and building short interest. The new CEO, the segment restructuring, and the broader AI-driven claims automation trend that is reshaping the TPA sector globally will all be themes Swain needs to address on May 4.
What to watch: whether Q1 results under the new segment structure show margin improvement — and whether short sellers add further ahead of the call or take profits into any post-print strength.
See the live data behind this article on ORTEX.
Open CRD.A on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
